Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1982 1
1985 1
1988 2
1989 1
1990 2
1994 1
1995 1
1996 1
1997 1
2000 2
2002 1
2003 1
2004 1
2005 2
2006 3
2007 3
2008 2
2009 4
2010 5
2011 5
2012 3
2013 6
2014 5
2015 9
2016 10
2017 10
2018 9
2019 11
2020 5
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 20185596

98 results
Results by year
Filters applied: . Clear all
Page 1
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators. van Aerts RMM, et al. Gastroenterology. 2019 Aug;157(2):481-491.e7. doi: 10.1053/j.gastro.2019.04.018. Epub 2019 Apr 22. Gastroenterology. 2019. PMID: 31022403 Clinical Trial.
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial.
Hogan MC, Chamberlin JA, Vaughan LE, Waits AL, Banks C, Leistikow K, Oftsie T, Madsen C, Edwards M, Glockner J, Kremers WK, Harris PC, LaRusso NF, Torres VE, Masyuk TV. Hogan MC, et al. Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1267-1278. doi: 10.2215/CJN.13661119. Epub 2020 Aug 25. Clin J Am Soc Nephrol. 2020. PMID: 32843370 Free PMC article. Clinical Trial.
98 results